Cardiac Lesions Induced by Testosterone: Protective Effects of Dexrazoxane and Trimetazidine
- 12 May 2009
- journal article
- research article
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 9 (2) , 64-69
Abstract
Further to our previous observation of post-mortem cardiac lesions after sudden death in several athletes with a history of anabolic steroid abuse, this study was intended to reproduce these lesions in rabbits administered testosterone oenanthate, a prototypic anabolic steroid abused by athletes, and to provide evidence for the protective effects of trimetazidine and dexrazoxane that are used as antianginal and cardioprotective drugs, respectively. Groups of six rabbits each were administered saline, testosterone, or a combination of testosterone and either trimetazidine or dexrazoxane for 3 months. Histologic cardiac lesions including necrosis, misshapen cell nuclei, interstitial and endocardial fibrosis, lymphocytic infiltrates, and vascular dystrophies were observed in testosterone-treated rabbits. In contrast, no significant lesions were observed in the animals treated with testosterone combined with either trimetazidine or dexrazoxane. This is the first study providing evidence for testosterone cardiotoxicity following sub-chronic exposure in laboratory animals. In addition, these results suggest the protective role of trimetazidine and dexrazoxane.Keywords
This publication has 22 references indexed in Scilit:
- Sudden anabolic steroid abuse-related death in athletesInternational Journal of Cardiology, 2007
- Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening ProgramJAMA, 2006
- ESC Study Group of Sports Cardiology Position Paper on adverse cardiovascular effects of doping in athletesEuropean Journal of Preventive Cardiology, 2006
- Kardiovaskuläre Nebenwirkungen von anabol-androgenen SteroidenHerz, 2006
- Role of Trimetazidine in Management of Ischemic CardiomyopathyThe American Journal of Cardiology, 2006
- Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuildersInternational journal of legal medicine, 2005
- Effects of Androgenic-Anabolic Steroids in AthletesSports Medicine, 2004
- Increased Premature Mortality of Competitive Powerlifters Suspected to Have Used Anabolic AgentsInternational Journal of Sports Medicine, 2000
- DexrazoxaneDrugs, 1998
- Causes of sudden death in competitive athletesJACC, 1986